<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T04:35:02Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/5066" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/5066</identifier><datestamp>2025-10-24T10:35:23Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Urinary neuropilin-1: a predictive biomarker for renal outcome in lupus nephritis</dc:title>
   <dc:creator>Torres-Salido, Maria Teresa</dc:creator>
   <dc:creator>Sanchis Marin, Mireia</dc:creator>
   <dc:creator>Solé Marce, Cristina</dc:creator>
   <dc:creator>Moline Marimon, Teresa</dc:creator>
   <dc:creator>Vidal, Marta</dc:creator>
   <dc:creator>Vidal Guitart, Xavier</dc:creator>
   <dc:creator>Ordi Ros, José</dc:creator>
   <dc:creator>Cortés Hernandez, Josefina</dc:creator>
   <dc:contributor>[Torres-Salido MT] Internal Medicine Department, Hospital Quironsalud del Vallés, Sabadell, Spain. [Sanchis M, Solé C, Ordi-Ros J, Cortés-Hernández J] Unitat del Lupus, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Moliné T, Vidal M] Servei de Patologia Renal, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Vidal X] Servei Farmacologia Clínica, Fundació Institut Català de Farmacologia, Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain.</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Lupus eritematós sistèmic</dc:subject>
   <dc:subject>Marcadors bioquímics</dc:subject>
   <dc:subject>Prognosi</dc:subject>
   <dc:subject>DISEASES::Immune System Diseases::Autoimmune Diseases::Lupus Erythematosus, Systemic::Lupus Nephritis</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Neuropilins::Neuropilin-1</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades del sistema inmune::enfermedades autoinmunes::lupus eritematoso sistémico::nefritis lúpica</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::neuropilinas::neuropilina-1</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::Diagnóstico::Pronóstico</dc:subject>
   <dc:description>Neuropilin-1; Lupus nephritis; Urinary biomarker</dc:description>
   <dc:description>Neuropilina-1; Nefritis lúpica; Biomarcador urinario</dc:description>
   <dc:description>Neuropilina-1; Nefritis per lupus; Biomarcador urinari</dc:description>
   <dc:description>At present, Lupus Nephritis (LN) is still awaiting a biomarker to better monitor disease activity, guide clinical treatment, and predict a patient’s long-term outcome. In the last decade, novel biomarkers have been identified to monitor the disease, but none have been incorporated into clinical practice. The transmembrane receptor neuropilin-1 (NRP-1) is highly expressed by mesangial cells and its genetic deletion results in proteinuric disease and glomerulosclerosis. NRP-1 is increased in kidney biopsies of LN. In this work we were interested in determining whether urinary NRP-1 levels could be a biomarker of clinical response in LN. Our results show that patients with active LN have increased levels of urinary NRP-1. When patients were divided according to clinical response, responders displayed higher urinary and tissue NRP-1 levels at the time of renal biopsy. Areas under the receiver operating characteristic curve, comparing baseline creatinine, proteinuria, urinary NRP-1, and VEGFA protein levels, showed NRP-1 to be an independent predictor for clinical response. In addition, in vitro studies suggest that NRP-1could promote renal recovery through endothelial proliferation and migration, mesangial migration and local T cell cytotoxicity. Based on these results, NRP-1 may be used as an early prognostic biomarker in LN.</dc:description>
   <dc:description>This work was supported by grants from the Spain Government (Instituto de Salud Carlos III). This research also received donations from Catalan Lupus Foundation and A.Bosch Foundation.</dc:description>
   <dc:date>2020-07-06T13:03:45Z</dc:date>
   <dc:date>2020-07-06T13:03:45Z</dc:date>
   <dc:date>2019-09-17</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Torres-Salido MT, Sanchis  M,  Solé  C, Moliné T, Vidal M, Vidal  X,  et al. Urinary neuropilin-1: a predictive biomarker for renal outcome in lupus nephritis. Int J Mol Sci. 2019 Sep 17;20(18):4601.</dc:identifier>
   <dc:identifier>1422-0067</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/5066</dc:identifier>
   <dc:identifier>10.3390/ijms20184601</dc:identifier>
   <dc:identifier>31533337</dc:identifier>
   <dc:identifier>000489100500280</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/5066</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>International Journal of Molecular Sciences;20(18)</dc:relation>
   <dc:relation>https://www.mdpi.com/1422-0067/20/18/4601</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>MDPI</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>